China’s self-driving cars need to adapt to EU tech compliance regulations | Winning bids for drug procurement contracts to be kept confidential as regulators aim to balance competition and sustainability | China adds U.S.-linked ETFs in latest expansion of cross-border ETF Connect program
Forced tech transfers are a possible precondition for Chinese firms in Europe. | China closes unclarified aspects of the cross-border data transfer regime. | Over RMB 11 million in penalties signal banking regulators’ focus on data security and risk control.
Jianwei (Jerry) Fang, Rui Yang, Ke Dong, Songyang Wang, Jiaying Jiang and Yongan Shen of Zhong Lun Law Firm analyze China’s latest strengthened enforcement in export control and countermeasure actions. The authors examine how newly-announced restrictions and countermeasures reflect China’s strategy of reciprocal regulatory response, the expansion of its extraterritorial jurisdiction through origin-based control mechanisms, and the increasing compliance challenges for foreign businesses operating in or with China
Patrick Gu and Lin Zang of Llinks Law Offices offer a practical analysis of the practical implications of a new set of Guidelines on the use of non-compete clauses
U.S. export controls extended to subsidiaries of Chinese companies | PBOC broadens foreign access to its bond market by aligning China’s repo framework with global standards | U.S. court rules that DJI failed to counter proof of its military links.
Fang Qi and Ran Duan of Fangda Partners analyze a recent Chinese court decision which, for the first time, recognized that the use of trademarks in a virtual context may infringe rights in the real world
Eight landmark AI judgments set precedents on AI-related infringement. | China attempts to displace the U.S. and Germany in determining industry standards. | Increased foreign interest in Chinese stocks adds US$3 trillion to market.
Meihua Liang and Yuting Chen of Commerce & Finance Law Offices present an analysis of China's distinct regulatory model governing digital assets, and its legal implications for market participants
U.S. pharma raises alarm over Trump’s proposed measures against Chinese drugs; China clarifies the type of employees to be bound by non-compete clauses; and Some stablecoin issuers complain that Hong Kong’s regime is too stringent.
Part I of this series explained China’s general rules on foreign-related jurisdiction. In Part II, Jianwei(Jerry) Fang, Ke Dong and Haoyi Sun of Zhong LunLaw Firm show how Chinese courts will, in practice, assert jurisdiction in civil, administrative or criminal contexts involving foreign elements, and describe a new “blocking statute” that reflects China’s response to foreign long-arm claims.